SoMUK — Society of Mesotherapy UK — Medical Advisory
Clinical Research &
Product Evaluation
by SoMUK
SoMUK is the United Kingdom's authoritative professional society for mesotherapy — and a recognised scientific partner for pharmaceutical companies, medical device manufacturers, and aesthetic product innovators seeking independent, evidence-based clinical evaluation of their products in a real-world UK practice setting.
Enquire About a Partnership →Why SoMUK
“We are not just a training organisation. We are a clinical authority. When a company needs credible, independent evaluation of a new product in mesotherapy, skin boosters, exosomes or polynucleotides — backed by a professional society, carried out by specialist practitioners, and published to a standard the industry can trust — SoMUK is uniquely positioned to deliver that.”
What SoMUK Offers to Industry Partners
SoMUK works with pharmaceutical companies, medical device manufacturers, and aesthetic product innovators to provide independent clinical evaluation, product outcome studies, and real-world evidence generation in the field of injectable aesthetic medicine.
Our Medical Advisory Board — a panel of specialist doctors practising across the United Kingdom, France, Russia, Ukraine, and South Korea — can design, conduct, and report on clinical studies that give your product the independent, authoritative evidence base it needs to reach the UK and international aesthetic medicine market with confidence.
If your company is developing, launching, or seeking to strengthen the evidence base for a product in any of the treatment categories below, we invite you to contact us to discuss a research partnership.
Treatment Areas — Our Clinical Expertise
SoMUK's clinical expertise spans the full range of injectable aesthetic and pain management techniques. We can design and conduct product evaluations across all of the following treatment categories:
| Treatment Category | What we can evaluate for your product |
|---|---|
| Mesotherapy | Cocktail efficacy, ingredient bioavailability, skin quality outcomes, hair restoration outcomes, patient satisfaction, technique optimisation, protocol development, comparative studies vs existing products or techniques. |
| Skin Boosters | Hydration outcomes, skin elasticity, luminosity, patient-reported outcomes, longevity of effect, comparison with existing CE marked products, injection protocol assessment, practitioner usability evaluation. |
| Exosomes | Regenerative outcomes, skin firmness and texture improvement, post-procedure recovery support, comparative studies with PRP and polynucleotides, safety assessment in injectable use, combined protocol outcomes. |
| Polynucleotides (PDRN / PN) | Tissue repair outcomes, collagen and elastin stimulation, periorbital and skin laxity applications, hair restoration efficacy, pain management applications, combined protocol studies with mesotherapy and skin boosters. |
| Pain Mesotherapy | Musculoskeletal pain outcomes (osteoarthritis, low back pain, tendonitis, cervical pain), comparison with corticosteroid injection, function score improvement (WOMAC, VAS, Oxford Knee Scale), quality of life assessment. |
| Combined Protocols | Multi-product protocol development and outcome assessment. Evaluating the additive or synergistic effect of your product when used alongside existing treatments such as Botox, dermal fillers, laser, or radiofrequency devices. |
| New Products & Formulations | First clinical use assessment, practitioner usability studies, patient tolerability and satisfaction, outcome reporting for CE marking dossier support, real-world evidence for post-market clinical follow-up (PMCF) requirements. |
What a SoMUK Research Partnership Includes
01
Independent Clinical Evaluation
Product assessment by SoMUK Medical Advisory Board members in a real-world UK clinical practice setting. Independent of the manufacturer. Results reported objectively.
02
Outcome Studies & Data Collection
Structured data collection using validated outcome measures (VAS, GAIS, WSRS, FACE-Q, WOMAC, Oxford Knee Scale and others). Patient-reported and practitioner-reported outcomes.
03
Protocol Development
Collaborative development of injection protocols, treatment sequences, and clinical guidelines for your product — grounded in the clinical expertise of our advisory board and the real-world experience of our practitioner network.
04
Written Clinical Reports & Publications
Formal written outcome reports suitable for internal use, regulatory dossiers, post-market clinical follow-up (PMCF), or as the basis for peer-reviewed publication. Authored by SoMUK Medical Advisory Board members.
05
Practitioner Network Access
Access to SoMUK's UK-wide network of accredited mesotherapy practitioners for multi-centre studies, larger sample studies, and real-world evidence generation beyond the advisory board's own practice.
06
SoMUK Authority & Endorsement
Research conducted under the SoMUK name carries the credibility of the UK's leading professional mesotherapy society. SoMUK's involvement signals to the market that a product has been evaluated to the highest professional standard.
Why Choose SoMUK as Your Research Partner
There are many routes to clinical evidence generation. SoMUK offers a combination of qualities that is difficult to find in a single partner:
Professional Society Authority
SoMUK is the UK's recognised professional society for mesotherapy — not a commercial training company. Research conducted under our name carries the weight of a professional institution.
International Board
Our advisory board spans England, France, Russia, Ukraine, and South Korea — giving your product evaluation an international clinical perspective in a single partnership.
Specialism in Injectable Aesthetics
We are not generalists. Our entire clinical focus is on injectable aesthetic and pain medicine — mesotherapy, skin boosters, exosomes, polynucleotides. This is all we do.
Active Practitioner Network
SoMUK members are active practitioners currently injecting patients. Studies can be conducted in real clinical settings with genuine patient populations — not artificial trial environments.
Regulatory Awareness
Our board understands the UK regulatory framework for medical devices and injectables — MHRA, MDR, UKCA. We can help ensure your evaluation meets the requirements of a post-market clinical follow-up (PMCF) study.
Training Integration
Products evaluated and validated by SoMUK can be integrated into our training curriculum — giving your product direct access to the practitioners forming their product preferences at the point of clinical education.
How a Partnership Works
Every research partnership is tailored to the specific product, indication, and evidence needs of the company. The process typically follows these stages:
-
1Initial EnquiryContact SoMUK by email or phone with a brief description of your product, the indication you want evaluated, and the type of evidence you are seeking. We will respond within 2 working days to arrange a preliminary discussion.
-
2Scoping DiscussionA call or meeting with SoMUK Medical Advisory Board members to understand your product, its intended use, the existing evidence base, and the specific questions you need answered. We discuss the most appropriate evaluation methodology, outcome measures, and timeline.
-
3Protocol DesignSoMUK designs the evaluation protocol — number of subjects, treatment schedule, outcome measures, data collection methods, follow-up intervals, and reporting format. This is agreed with the company before any clinical work begins.
-
4Clinical EvaluationThe evaluation is conducted by SoMUK Medical Advisory Board members in clinical practice at 22 Harley Street, London, and/or across SoMUK's wider practitioner network depending on the scale of the study. All treatments are carried out to SoMUK's clinical standards.
-
5Outcome ReportingData is analysed and a formal written outcome report is produced, authored by SoMUK Medical Advisory Board members. Reports are suitable for internal use, regulatory submissions, PMCF documentation, or as the basis for peer-reviewed publication.
-
6Ongoing PartnershipMany SoMUK research partnerships develop into ongoing relationships — including product integration into SoMUK training curricula, SoMUK endorsement of CE marked products, and sponsorship partnerships that give your brand direct access to the UK mesotherapy practitioner community.
The Medical Advisory Board
All SoMUK clinical evaluations are designed and conducted by members of the SoMUK Medical Advisory Board — an international panel of specialist doctors with active clinical practices across four countries and two clinical disciplines.
Dr Philippe Hamida-Pisal
England · France · International
Founder of SoMUK. Key Opinion Leader in aesthetic and regenerative medicine. PhD Dermatology. GMC Registered. 22 Harley Street, London. Practising internationally in aesthetic mesotherapy, skin boosters, exosomes, polynucleotides, and combined protocols.
Dr Tania Robakowska
England · Russia · Ukraine
Aesthetic medicine specialist with trilingual clinical practice across the United Kingdom, Russia, and Ukraine. Expertise in mesotherapy protocols and skin rejuvenation across diverse patient populations and clinical environments.
Dr Corinne Dubois-Gonet
England · France
Aesthetic medicine specialist with clinical practice in England and France. Trained in the French mesotherapy tradition where the technique was founded. Brings the authentic clinical heritage of French aesthetic medicine to the board's research work.
Dr Jihyun Byun
England · South Korea
Aesthetic medicine specialist practising in England and South Korea. Korean aesthetic medicine is globally recognised for its technical precision and clinical innovation in injectable and regenerative treatments — a perspective she brings directly to SoMUK research.
Conflicts of Interest & Independence
SoMUK is committed to the integrity of all research conducted under its name. All evaluations are conducted independently of the sponsoring company. Outcome data is reported objectively regardless of results. SoMUK does not endorse products prior to evaluation, and evaluation findings are never manipulated to serve commercial interests. Companies engaging SoMUK as a research partner agree to these terms before any work begins.
“The aesthetic medicine market is full of products claiming to be the next breakthrough. What separates those that endure from those that disappear is evidence — independent, clinical, credible evidence from practitioners who actually use these techniques every day. That is what SoMUK provides. We are not here to validate marketing claims. We are here to find out what actually works — and to report it honestly.”
— SoMUK Medical Advisory Board — 22 Harley Street, London
Research Partnership Enquiries
Contact the SoMUK Medical Advisory Board
To discuss a clinical evaluation, outcome study, or product research partnership, contact us directly. We respond to all research enquiries within 2 working days.
Please include a brief description of your product and the type of evaluation you are seeking.
All enquiries are treated in strict confidence.
All enquiries are treated in strict confidence.